First Quadrant’s Amphastar Pharmaceuticals AMPH Stock Holding History

First Quadrant’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,562	Closed	-$36K	–	161
2021 Q4	$36K	Buy	+1,562	New	+$31.9K	﹤0.01%	444
2021 Q1	–	Sell	-560	Closed	-$11K	–	568
2020 Q4	$11K	Buy	560 +97	+21%	+$1.89K	﹤0.01%	563
2020 Q3	$9K	Sell	463 -13,972	-97%	-$281K	﹤0.01%	606
2020 Q2	$324K	Buy	+14,435	New	+$264K	0.04%	336
2019 Q1	–	Sell	-3,388	Closed	-$67K	–	706
2018 Q4	$67K	Buy	+3,388	New	+$66.8K	0.01%	700
2017 Q1	–	Sell	-3,452	Closed	-$64K	–	796
2016 Q4	$64K	Sell	3,452 -40,917	-92%	-$796K	﹤0.01%	746
2016 Q3	$842K	Buy	+44,369	New	+$805K	0.02%	457

Other funds holding AMPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

First Quadrant's AMPH Position: Q1 2022 in Review

First Quadrant sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2022, closing a stake of 1,562 shares — an estimated $36K sold.

First Quadrant first reported a position in AMPH in Q3 2016 and held it in 7 quarters. The position peaked at $842K in Q3 2016. 203 funds tracked by Wall St. Rank hold AMPH as of Q1 2022.

First Quadrant reported no remaining Amphastar Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
First Quadrant sold 1,562 Amphastar Pharmaceuticals shares in Q1 2022, an estimated $36K.
First Quadrant first reported a position in Amphastar Pharmaceuticals in Q3 2016 and held it in 7 quarters.
First Quadrant's Amphastar Pharmaceuticals position peaked at $842K in Q3 2016.
203 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2022.

Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.